Drinking Coffee May Cut Risk of Chronic Liver Disease, Study Suggests (theguardian.com) 74
An anonymous reader quotes a report from The Guardian: From espresso to instant, coffee is part of the daily routine for millions. Now research suggests the brew could be linked to a lower chance of developing or dying from chronic liver disease. Chronic liver disease is a major health problem around the world. According to the British Liver Trust, liver disease is the third leading cause of premature death in the UK, with deaths having risen 400% since 1970. Writing in the journal BMC Public Health, Roderick and colleagues report how they analyzed data from 494,585 participants in the UK Biobank -- a project designed to help unpick the genetic and environmental factors associated with particular conditions. All participants were aged 40 to 69 when they signed up to the project, with 384,818 saying they were coffee drinkers at the outset compared with 109,767 who did not consume the beverage.
The team looked at the liver health of the participants over a median period of almost 11 years, finding 3,600 cases of chronic liver disease, with 301 deaths, and 1,839 cases of simple fatty liver disease. The analysis revealed that after taking into account factors such as body mass index, alcohol consumption, and smoking status, those who drank any amount of coffee, and of any sort, had a 20% lower risk of developing chronic liver disease or fatty liver disease (taken together) than those who did not consume the brew. The coffee drinkers also had a 49% lower risk of dying from chronic liver disease. The team said the magnitude of the effect increased with the amount of coffee consumed, up to about three to four cups a day, "beyond which further increases in consumption provided no additional benefit." A reduction in risk was also found when instant, decaffeinated and ground coffee were considered separately -- although the latter linked to the largest effect.
The team looked at the liver health of the participants over a median period of almost 11 years, finding 3,600 cases of chronic liver disease, with 301 deaths, and 1,839 cases of simple fatty liver disease. The analysis revealed that after taking into account factors such as body mass index, alcohol consumption, and smoking status, those who drank any amount of coffee, and of any sort, had a 20% lower risk of developing chronic liver disease or fatty liver disease (taken together) than those who did not consume the brew. The coffee drinkers also had a 49% lower risk of dying from chronic liver disease. The team said the magnitude of the effect increased with the amount of coffee consumed, up to about three to four cups a day, "beyond which further increases in consumption provided no additional benefit." A reduction in risk was also found when instant, decaffeinated and ground coffee were considered separately -- although the latter linked to the largest effect.